Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency
Wednesday, March 08, 2017
Controversy exists regarding the safety of testosterone replacement therapy (TRT) following recent reports of an increased risk of adverse cardiovascular events.
To investigate the association between TRT and cardiovascular outcomes in men with androgen deficiency.
A retrospective cohort study was conducted within an integrated health care delivery system. Men at least 40 years old with evidence of androgen deficiency either by a coded diagnosis and/or a morning serum total testosterone level of less than 300 ng/dL were included. The eligibility window was January 1, 1999, to December 31, 2010, with follow-up through December 31, 2012.
Click here to read the full publication.
Source: American Medical Association